Fingolimod, cognition and MRI: a longitudinal study

被引：0
|
作者：
Pfaff, Line [1 ]
Mondino, Mary [2 ]
Noblet, Vincent [2 ]
Berthe, Carole [3 ,4 ]
Lanotte, Livia [3 ,4 ]
Kremer, Laurent [3 ,4 ]
Bigaut, Kevin [3 ,4 ]
Collongues, Nicolas [3 ,4 ]
De Seze, Jerome [1 ,3 ,4 ]
机构：
[1] Univ Strasbourg, Biopathol Myelin Neuroprotect & Therapeut Strateg, INSERM U1119, Strasbourg, France
[2] Univ Strasbourg, CNRS, UMR 7357, FMTS,ICube, Strasbourg, France
[3] Univ Hosp Strasbourg, CIC Clin Invest Ctr INSERM 1434, Strasbourg, France
[4] Univ Hosp Strasbourg, Dept Neurol, Strasbourg, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1137/1712
引用
收藏
页码：755 / 755
页数：1
相关论文
共 50 条
  • [1] Fingolimod and cognition: a longitudinal study
    Pfaff, L.
    Berthe, C.
    Bigaut, K.
    Kremer, L.
    Fleury, M.
    Collongues, N.
    De Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 723 - 723
  • [2] Teriflunomide, cognition and MRI: a longitudinal study
    Pfaff, Line
    Mondino, Mary
    Loeb, Quentin
    Noblet, Vincent
    De Seze, Jerome
    Berthe, Carole
    Kremer, Laurent
    Bigaut, Kevin
    Collongues, Nicolas
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 694 - 694
  • [3] Teriflunomide, cognition and MRI: A longitudinal study
    Pfaff, L.
    Mondino, M.
    Loeb, Q.
    Noblet, V.
    Berthe, C.
    Kremer, L.
    Bigaut, K.
    Collongues, N.
    De Seze, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [4] Teriflunomide and cognition: a longitudinal study
    Pfaff, L.
    Berthe, C.
    Bigaut, K.
    Kremer, L.
    Fleury, M.
    Collongues, N.
    De Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 724 - 725
  • [5] Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study
    Knopman, David S.
    Mosley, Thomas H.
    Catellier, Diane J.
    Coker, Laura H.
    ALZHEIMERS & DEMENTIA, 2009, 5 (03) : 207 - 214
  • [6] A longitudinal study on the stability of the need for cognition
    Bruinsma, Jeroen
    Crutzen, Rik
    PERSONALITY AND INDIVIDUAL DIFFERENCES, 2018, 127 : 151 - 161
  • [7] A longitudinal real-life comparison study of natalizumab and fingolimod
    Lanzillo, R.
    Carotenuto, A.
    Moccia, M.
    Sacca, F.
    Russo, C. V.
    Massarelli, M.
    De Rosa, A.
    Morra, V. Brescia
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (03): : 217 - 222
  • [8] A 14-year longitudinal study of cardiovascular risk factors and cognition: The atherosclerosis risk in communities (ARIC) MRI study
    Mosley, Thomas H.
    Catellier, Diane J.
    Coker, Laura H.
    Knopman, David
    NEUROLOGY, 2007, 68 (12) : A169 - A169
  • [9] Longitudinal study of normal cognition in Parkinson disease
    Pigott, Kara
    Rick, Jacqueline
    Xie, Sharon X.
    Hurtig, Howard
    Chen-Plotkin, Alice
    Duda, John E.
    Morley, James F.
    Chahine, Lama M.
    Dahodwala, Nabila
    Akhtar, Rizwan S.
    Siderowf, Andrew
    Trojanowski, John Q.
    Weintraub, Daniel
    NEUROLOGY, 2015, 85 (15) : 1276 - 1282
  • [10] Brain MRI assessment and patient outcomes in multiple sclerosis patients on fingolimod in a real world clinical setting: feasibility of a pilot longitudinal study
    Zivadinov, R.
    Khan, N.
    Medin, J.
    Korn, J.
    Bergsland, N.
    Christoffersen, P.
    Dwyer, M. G.
    Price, J.
    Carl, E.
    Bonzani, I.
    Silva, D.
    Weinstock-Guttman, B.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 789 - 790
12345